Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Meden

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Elevated serum levels of a c-erbB-2 oncogene product in ovarian cancer patients and in pregnancyH Meden, D Marx, A Fattahi, et al.
British Journal of Cancer|May 19, 2000
nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinomaJ Schneider, M Pollán, E Jiménez, et al.
European Journal of Gynaecological Oncology|October 31, 2007
Use of lysophosphatidic acid in the management of benign and malignant ovarian tumorsB Pozlep, M Meleh, B Kobal, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 10, 2007
Isopropanolic black cohosh extract and recurrence-free survival after breast cancerH H Henneicke-von Zepelin, H Meden, K Kostev, et al.
Therapeutic Drug Monitoring|June 1, 1997
A simple and reliable reverse-phase high-performance liquid chromatographic procedure for determination of paclitaxel (taxol) in human serumM Andreeva, P D Niedmann, L Binder, et al.
Anticancer Research|May 1, 1997
Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancerD Marx, C Binder, H Meden, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1994
Overexpression of the oncogene c-erb B2 in primary ovarian cancer: evaluation of the prognostic value in a Cox proportional hazards multiple regressionH Meden, D Marx, W Rath, et al.
Climacteric : the Journal of the International Menopause Society|October 5, 2021
Weight gain in menopause: systematic review of adverse events in women treated with black cohoshB Naser, C Castelo-Branco, H Meden, et al.
Anticancer Research|January 18, 2003
Treosulfan in the treatment of advanced ovarian cancer: a randomised co-operative multicentre phase III-studyG P Breitbach, H Meden, H Schmid, et al.
Acta Europaea Fertilitatis|July 1, 1988
Transvaginal ultrasound or laparoscopy for oocyte retrieval (experiences in the Ljubljana IVF program)T Tomazevic, M Pompe-Tansek, H Meden-Vrtovec, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Elevated serum levels of a c-erbB-2 oncogene product in ovarian cancer patients and in pregnancyH Meden, D Marx, A Fattahi, et al.
British Journal of Cancer|May 19, 2000
nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinomaJ Schneider, M Pollán, E Jiménez, et al.
European Journal of Gynaecological Oncology|October 31, 2007
Use of lysophosphatidic acid in the management of benign and malignant ovarian tumorsB Pozlep, M Meleh, B Kobal, et al.
International Journal of Clinical Pharmacology and Therapeutics|April 10, 2007
Isopropanolic black cohosh extract and recurrence-free survival after breast cancerH H Henneicke-von Zepelin, H Meden, K Kostev, et al.
Therapeutic Drug Monitoring|June 1, 1997
A simple and reliable reverse-phase high-performance liquid chromatographic procedure for determination of paclitaxel (taxol) in human serumM Andreeva, P D Niedmann, L Binder, et al.
Anticancer Research|May 1, 1997
Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancerD Marx, C Binder, H Meden, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1994
Overexpression of the oncogene c-erb B2 in primary ovarian cancer: evaluation of the prognostic value in a Cox proportional hazards multiple regressionH Meden, D Marx, W Rath, et al.
Climacteric : the Journal of the International Menopause Society|October 5, 2021
Weight gain in menopause: systematic review of adverse events in women treated with black cohoshB Naser, C Castelo-Branco, H Meden, et al.
Anticancer Research|January 18, 2003
Treosulfan in the treatment of advanced ovarian cancer: a randomised co-operative multicentre phase III-studyG P Breitbach, H Meden, H Schmid, et al.
Acta Europaea Fertilitatis|July 1, 1988
Transvaginal ultrasound or laparoscopy for oocyte retrieval (experiences in the Ljubljana IVF program)T Tomazevic, M Pompe-Tansek, H Meden-Vrtovec, et al.
Pageof 11